ReviewFrontiers in pharmacology2024

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review.

Chao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.